title: Clinical outcomes of atypical carcinoid tumors of the lung and thymus: 7-year experience of a rare malignancy at single institute.
abstract: Atypical carcinoid tumors above the diaphragm are extremely rare and are associated with unfavorable clinical outcomes compared to typical carcinoid tumors. We described various clinical and histological features and investigated outcomes in patients with atypical carcinoid tumor of the lung and thymus. Medical records were reviewed in patients diagnosed with atypical carcinoid tumor of the lung or thymus at Samsung Medical Center between December 2003 and April 2010. We reviewed patient characteristics and treatment modalities and analyzed patient outcome in terms of disease-free survival and overall survival. Of the nineteen study patients, there were twelve patients with atypical carcinoid tumors of the lung and seven patients with thymic ones. All patients except one underwent complete resection as the main treatment. All patients who had tumors with lesser mitoses (≤5/10 high-power fields) are presently alive; moreover, they are all free of recurrence except for one patient who is also alive with recurrent tumor without any palliative treatment. Distant metastasis after curative resection developed in six patients and two of them died of progressive disease 25-31 months after recurrence even after palliative systemic chemotherapy. Atypical carcinoid tumor of the lung and thymus was a malignant disease that was prone to metastasize to distant sites even after curative resection and adjuvant treatment. Number of mitosis was a predicting factor for recurrence of disease and death in patients with atypical carcinoid tumor of the lung and thymus.
authors: Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-dong, Gangnam-gu, Seoul 135-710, Republic of Korea. hborbor@naver.com
authors: Boram
authors: B
authors: Han
authors: Jong-Mu
authors: JM
authors: Sun
authors: Jin Seok
authors: JS
authors: Ahn
authors: Keunchil
authors: K
authors: Park
authors: Myung-Ju
authors: MJ
authors: Ahn
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002276:Carcinoid Tumor / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012189:Retrospective Studies; D013953:Thymus Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy
references: J Thorac Cardiovasc Surg. 1972 Sep;64(3):413-21
references: 5054879
references: J Clin Oncol. 2008 Jun 20;26(18):3063-72
references: 18565894
references: Lancet. 1998 Sep 5;352(9130):799-805
references: 9737302
references: Eur J Cardiothorac Surg. 2007 Feb;31(2):192-7
references: 17196822
references: Ann Surg Oncol. 2003 Jul;10(6):697-704
references: 12839856
references: Radiographics. 2006 Jan-Feb;26(1):41-57; discussion 57-8
references: 16418242
references: Am J Surg Pathol. 1991 Jun;15(6):529-53
references: 1709558
references: Semin Diagn Pathol. 1999 Feb;16(1):32-41
references: 10355652
references: Indian J Chest Dis Allied Sci. 2005 Jul-Sep;47(3):213-5
references: 16022152
references: Cancer. 1972 Apr;29(4):1075-83
references: 4401563
references: Chest. 2001 Jun;119(6):1647-51
references: 11399686
references: Chest. 2003 Jul;124(1):141-6
references: 12853516
references: Ann Oncol. 2010 May;21 Suppl 5:v220-2
references: 20555085
references: Ann Thorac Cardiovasc Surg. 1999 Aug;5(4):211-9
references: 10508944
references: Ann Thorac Surg. 2009 Dec;88(6):2004-6
references: 19932277
references: J Cardiovasc Surg (Torino). 2000 Feb;41(1):131-5
references: 10836239
references: Chest. 2001 Apr;119(4):1143-50
references: 11296182
references: Am J Surg Pathol. 1983 Dec;7(8):775-85
references: 6318582
references: Lung Cancer. 2011 Jan;71(1):34-41
references: 20462655
references: Am J Surg Pathol. 1998 Aug;22(8):934-44
references: 9706973